These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9395142)

  • 21. An infectious cDNA clone of a cytopathic hepatitis A virus: genomic regions associated with rapid replication and cytopathic effect.
    Zhang H; Chao SF; Ping LH; Grace K; Clarke B; Lemon SM
    Virology; 1995 Oct; 212(2):686-97. PubMed ID: 7571438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An inactivated hepatitis A viral vaccine of cell culture origin.
    Provost PJ; Hughes JV; Miller WJ; Giesa PA; Banker FS; Emini EA
    J Med Virol; 1986 May; 19(1):23-31. PubMed ID: 3009703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation and propagation of hepatitis A virus in hepatoma cell cultures.
    Friedman-Alvermann B; Müller D; Spies K
    Acta Virol; 1985 Dec; 29(6):482-6. PubMed ID: 2869659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytopathology, plaque assay, and heat inactivation of hepatitis A virus strain HM175.
    Anderson DA
    J Med Virol; 1987 May; 22(1):35-44. PubMed ID: 3035078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of the inactivation kinetics of hepatitis A virus in human plasma products using a simple TCID50 assay.
    Barrett PN; Meyer H; Wachtel I; Eibl J; Dorner F
    J Med Virol; 1996 May; 49(1):1-6. PubMed ID: 8732864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient neutralizing activity of cocktailed recombinant human antibodies against hepatitis A virus infection in vitro and in vivo.
    Cao J; Meng S; Li C; Ji Y; Meng Q; Zhang Q; Liu F; Li J; Bi S; Li D; Liang M
    J Med Virol; 2008 Jul; 80(7):1171-80. PubMed ID: 18461629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enzyme immunoassay of mumps virus in cell culture with peroxidase-labelled virus specific monoclonal antibodies and its application for determination of antibodies.
    van Tiel FH; Kraaijeveld CA; Baller J; Harmsen T; Oosterlaken TA; Snippe H
    J Virol Methods; 1988 Oct; 22(1):99-108. PubMed ID: 3058739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a plaque assay for a cytopathic, rapidly replicating isolate of hepatitis A virus.
    Cromeans T; Sobsey MD; Fields HA
    J Med Virol; 1987 May; 22(1):45-56. PubMed ID: 3035079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunofluorescence and immunoperoxidase assays for the titration of infectious hepatitis A virus (HAV).
    Nadala EC; Loh PC
    J Virol Methods; 1990 May; 28(2):117-24. PubMed ID: 2164520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of IgM against hepatitis A virus using tissue culture derived antigen.
    Chitambar SD; Arankalle VA; Banerjee K
    Indian J Med Res; 1991 Jan; 93():19-21. PubMed ID: 1850714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of complement-dependent cytolytic antibodies in hepatitis A virus infection.
    Gabriel P; Vallbracht A; Flehmig B
    J Med Virol; 1986 Sep; 20(1):23-31. PubMed ID: 3020167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody response to nonstructural proteins of hepatitis A virus following infection.
    Robertson BH; Jia XY; Tian H; Margolis HS; Summers DF; Ehrenfeld E
    J Med Virol; 1993 May; 40(1):76-82. PubMed ID: 8390561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Host immune response to hepatitis A virus.
    Stapleton JT
    J Infect Dis; 1995 Mar; 171 Suppl 1():S9-14. PubMed ID: 7876654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal antibodies against an immunodominant and neutralizing epitope on hepatitis A virus antigen.
    Crevat D; Crance JM; Chevrinais AM; Passagot J; Biziagos E; Somme G; Deloince R
    Arch Virol; 1990; 113(1-2):95-8. PubMed ID: 1696807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of an inactivated hepatitis A vaccine in pre- and postexposure conditions in marmosets.
    D'Hondt E; Purcell RH; Emerson SU; Wong DC; Shapiro M; Govindarajan S
    J Infect Dis; 1995 Mar; 171 Suppl 1():S40-3. PubMed ID: 7876647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variation in antibody reactivity to the hepatitis C virus by comparative immunoscreening and enzyme immunoassay.
    Gish RG; Warmerdam MT; Zeldis JB; Keeffe EB; Nakazato P; Lim J; Cox K; Kuramoto IK; Fry KE; Yarbough PO
    Viral Immunol; 1993; 6(1):49-54. PubMed ID: 7682814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indigenous anti-hepatitis A virus IgM capture ELISA for the diagnosis of hepatitis A.
    Chitambar SD; Murthy-Grewal S; Bokil M; Arankalle VA; Gore MM; Banerjee K
    Indian J Med Res; 1994 Jun; 99():243-51. PubMed ID: 8088883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of anti-idiotypic antibodies mimicking antibody- and receptor-binding sites on hepatitis A virus.
    Kiyohara T; Totsuka A; Yoneyama T; Ishii K; Ito T; Wakita T
    Arch Virol; 2009; 154(8):1263-9. PubMed ID: 19578927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A simple method for clonal selection of hepatitis A virus based on recovery of virus from radioimmunofocus overlays.
    Lemon SM; Jansen RW
    J Virol Methods; 1985 Jun; 11(2):171-6. PubMed ID: 2991315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation of a prototype inactivated hepatitis A virus vaccine from infected cell cultures.
    Binn LN; Bancroft WH; Lemon SM; Marchwicki RH; LeDuc JW; Trahan CJ; Staley EC; Keenan CM
    J Infect Dis; 1986 Apr; 153(4):749-56. PubMed ID: 3005435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.